HeiligHartziekenhuis Lier
- Address
- Mechelsestraat 24, 2500 Lier, Belgium
Heilig-Hartziekenhuis Lier - Clinical Research Center
Heilig-Hartziekenhuis Lier is a clinical research facility actively engaged in diverse therapeutic areas, demonstrating expertise across multiple medical specialties. The center participates in both early-phase and late-phase clinical trials, contributing to the advancement of treatment strategies for complex chronic conditions and cancer management.
- Oncology research focusing on breast cancer and metastatic prostate cancer, including novel hormonal therapy strategies and targeted treatments
- Gastroenterology trials investigating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis with optimized biologic therapies
- Pain management and neurology studies, including acute migraine treatment and chronic pain interventions for spinal conditions
The research center demonstrates particular strength in evaluating patient-centered outcomes and quality of life measures. Their portfolio includes investigations of hormone receptor-positive breast cancer in elderly populations, androgen deprivation therapy for metastatic hormone-sensitive prostate cancer, and innovative approaches to medication tapering protocols for Persistent Spinal Pain Syndrome Type II. The center's participation in CGRP antagonist trials for acute migraine treatment and subcutaneous biologic delivery systems for inflammatory bowel disease reflects their commitment to advancing personalized medicine and improving treatment convenience for patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HeiligHartziekenhuis Lier
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Atogepant in Acute Migraine Treatment: A Randomized, Double-Blind, Placebo-Controlled Study | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Apr 2024 | — |
IMP list
lock Showing 1 of 24 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abiraterone | 1 | Unknown | 2025-05-23 | 2025-05-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.